Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

July

7

electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome

Study to be initiated with Mayo Clinic’s Post-COVID Care Clinic subjects ROCKAWAY, N.J., July 07,...

21

electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology

Evaluation results indicate nVNS therapy may potentially improve the course of patients’ COVID-19 symptoms...

11

electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store

E-Commerce platform allows patients to obtain prescriptions, purchase nVNS devices, and receive training ROCKAWAY,...

16

electroCore, Inc. Provides Update on Global Distribution Partners

ROCKAWAY, NJ, Dec. 16, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine...

14

electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine

Health Canada expands gammaCore label to include the acute and preventive treatment of migraine...

29

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1

Study evaluated impact of non-invasive vagus nerve stimulation in hospitalized COVID-19 patients ROCKAWAY, NJ, Sept....

24

electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation

Peer-reviewed paper available in the journal Communications Biology ROCKAWAY, NJ, June 24, 2021 (GLOBE NEWSWIRE) —...

2

electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinson’s Disease Patients

Peer-reviewed paper appears in the journal NPJ Parkinson’s Disease ROCKAWAY, N.J., June 02, 2021 (GLOBE NEWSWIRE) — electroCore,...

4

electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache

Randomized, multi-center, double-blind, parallel, sham-controlled trial enrolling up to 100 veterans and directed by...

26

electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders

Economic impact of gastroparesis can be substantial, with studies reporting 11% of patients disabled...

20

electroCore, Inc. Announces Exclusive Distribution Agreement with East Agency For Qatar

Introduction of nVNS therapy, gammaCore Sapphire, in the Middle East ROCKAWAY, NJ, April 20, 2021 (GLOBE...

5

electroCore, Inc. Announces Regulatory Approval in Canada

gammaCore Sapphire products approved for prevention and therapeutic treatment of migraine and cluster headache...

Recent developments

News

July

7

electroCore, Inc. Announces Study of gammaCore Sapphire™ for the Treatment of Post-COVID Syndrome

April

21

electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology

January

11

electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store

December

16

electroCore, Inc. Provides Update on Global Distribution Partners

October

14

electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine

September

29

electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1

June

24

electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation

June

2

electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinson’s Disease Patients

May

4

electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire™ (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache

April

26

electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders

April

20

electroCore, Inc. Announces Exclusive Distribution Agreement with East Agency For Qatar

April

5

electroCore, Inc. Announces Regulatory Approval in Canada